Autopsy report · NCT00418132

Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis

“Study terminated early due to difficulties in subject recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 years 5 months after it had already started.
• Ran for about 7 years 2 months before it stopped.
• 30 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

NYU Langone Health

Sponsor type

University, hospital or other

Conditions

Scleroderma, Systemic

Interventions

Thalidomide; Placebo thalidomide

Participants

30

Sites

1

Countries

United States

Trials that died the same way

• Early Versus Late Amniotomy Following EAB Cervical Ripening
  “Study was terminated due to difficulties in recruitment” (91% match in meaning)
• Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab
  “Study was terminated early because of slow recruitment” (90% match in meaning)
• A Study to Determine the Performance of the Press Fit Condylar (P.F.C.) Sigma RP-F Knee System
  “Study was terminated early due to prolonged recruitment period.” (89% match in meaning)
• Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks
  “Study terminated due to inadequate recruitment” (89% match in meaning)
• Alfuzosin Versus Placebo in Acute Urinary Retention
  “The study was early terminated due to slow and difficult recruitment” (88% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.